Patents by Inventor Miguel Izquierdo

Miguel Izquierdo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA
    Publication number: 20220017631
    Abstract: The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3? (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.
    Type: Application
    Filed: June 24, 2021
    Publication date: January 20, 2022
    Inventors: Minh Diem Vu, Klaus Strein, Bruno David Lourenco Paiva, Jesus Fernado San Miguel Izquierdo
  • BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA
    Publication number: 20220002427
    Abstract: The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3? (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.
    Type: Application
    Filed: June 24, 2021
    Publication date: January 6, 2022
    Inventors: Minh Diem Vu, Klaus Strein, Bruno David Lourenco Paiva, Jesus Fernado San Miguel Izquierdo
  • Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myeloma
    Patent number: 11124577
    Abstract: The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3? (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: September 21, 2021
    Assignee: ENGMAB SÀRL
    Inventors: Minh Diem Vu, Klaus Strein, Bruno David Lourenco Paiva, Jesus Fernado San Miguel Izquierdo
  • BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA
    Publication number: 20190263920
    Abstract: The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3? (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.
    Type: Application
    Filed: November 2, 2017
    Publication date: August 29, 2019
    Applicant: ENGMAB SARL
    Inventors: Minh Diem Vu, Klaus Strein, Bruno David Lourenco Paiva, Jesus Fernado San Miguel Izquierdo
  • Antitumoral treatments
    Patent number: 8258098
    Abstract: The present invention relates to combinations of aplidine or aplidine analogues with other titumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: September 4, 2012
    Assignee: Pharma Mar, S.A.
    Inventors: Glynn Thomas Faircloth, Pablo Manuel Aviles Marin, Doreen LePage, Jesus San Miguel Izquierdo, Atanasio Pandiella
  • ANTITUMORAL TREATMENTS
    Publication number: 20090246168
    Abstract: The present invention relates to combinations of aplidine or aplidine analogues with other antitumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma.
    Type: Application
    Filed: February 28, 2007
    Publication date: October 1, 2009
    Applicant: PHARMA MAR, S.A.
    Inventors: Glynn Thomas Faircloth, Pablo Manuel Aviles Marin, Doreen LePage, Jesus San Miguel Izquierdo, Atanasio Pandiella
  • Kahalalide Compositions for the Treatment of Psoriasis
    Publication number: 20080090757
    Abstract: Kahalalide compounds, in particular kahalalide F, are of use in a method to treat a mammal suffering from skin disease such as psoriasis while avoiding toxicity and leading to clinical improvement.
    Type: Application
    Filed: December 4, 2007
    Publication date: April 17, 2008
    Applicant: PHARMA MAR, S.A.U.
    Inventor: Miguel Izquierdo Delso
  • Use of Kahalalide Compounds for the Manufacture of a Medicament for the Treatment of Psoriasis
    Publication number: 20070032412
    Abstract: Kahalalide compounds, in particular kahalalide F, are of use in a method to treat a mammal suffering from skin disease with avoiding toxicity and leading to clinical improvement.
    Type: Application
    Filed: February 26, 2004
    Publication date: February 8, 2007
    Inventor: Miguel Izquierdo Delso
  • Kahalalide compounds for use in cancer therapy
    Publication number: 20050054555
    Abstract: Procedures for clinical trials of kahalalide compounds are provided, leading to new formulations of kahalalide compounds.
    Type: Application
    Filed: October 18, 2002
    Publication date: March 10, 2005
    Inventors: Jose Jimeno, Luis Lazaro, Ana Casado, Miguel Izquierdo, Jose Trigo, Jan Schellens, Luis Paz-Ares